cyclopropane has been researched along with Innate Inflammatory Response in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barkan, D; Glickman, MS; Hedhli, D; Huygen, K; Yan, HG | 1 |
| Chen, B; Gao, F; Glickman, MS; Jacobs, WR; Rao, V | 1 |
2 other study(ies) available for cyclopropane and Innate Inflammatory Response
| Article | Year |
|---|---|
Mycobacterium tuberculosis lacking all mycolic acid cyclopropanation is viable but highly attenuated and hyperinflammatory in mice.
Topics: Animals; Bacterial Proteins; Cyclopropanes; Cytokines; Female; Gene Expression Regulation, Bacterial; Inflammation; Methyltransferases; Mice; Mice, Inbred C57BL; Mutation; Mycobacterium tuberculosis; Mycolic Acids; Reverse Transcriptase Polymerase Chain Reaction | 2012 |
Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis -induced inflammation and virulence.
Topics: Animals; Bacterial Proteins; Cells, Cultured; Cord Factors; Cyclopropanes; Inflammation; Interferon-gamma; Lung; Macrophages; Membrane Lipids; Methyltransferases; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, SCID; Mycobacterium tuberculosis; Mycolic Acids; Survival Rate; Tuberculosis; Tumor Necrosis Factor-alpha | 2006 |